Shero, "TNT data from the glioma trial should be out by year's end. If I didn't already own TCLN I'd wait for the facts." That would be the 'safe' way to invest, but the money making way is to predict the results correctly. The way to predict correctly is to understand as much as possible and figure out what will happen.
By the time the results are published in all their gory, peer reviewed, FDA rubber-stamped, linear regression analyzed, documented and ASCO presented glory, the stock will have moved way beyond the current price if the results are good.
The profits are in prediction. Not in waiting for the facts.
But fools rush in and a fool and their money are soon parted.
Rick Harmon asked: "Davis..... where do we find preclinical data..... tox, efficacy, etc. for TNT?"
Does anyone know?
Thanks,
Maurice
PB, thanks for those links |
